FUJIFILM Biotechnologies

FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth Biotechnologies)

FUJIFILM Biotechnologies is a leading global contract development and manufacturing organization (CDMO) that was acquired by the Fujifilm Group in 2011. The company provides comprehensive capabilities for process development up to commercial supply, with world-class manufacturing facilities across Europe and the U.S. FUJIFILM Biotechnologies supports its global partners through exceptional manufacturing processes and offers solutions for a variety of complex biological products, advanced therapies, and vaccines. The new name emphasizes the connection and focus on innovative biotechnological solutions to support the life sciences sector.